These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 32265299

  • 1. High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11).
    Yamaguchi I, Yoshimura SH, Katoh H.
    J Biol Chem; 2020 May 15; 295(20):6936-6945. PubMed ID: 32265299
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Merlin/NF2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells.
    Yamaguchi I, Katoh H.
    J Biochem; 2024 Mar 04; 175(3):313-322. PubMed ID: 38102738
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells under Glucose Deprivation.
    Chen MC, Hsu LL, Wang SF, Hsu CY, Lee HC, Tseng LM.
    Cells; 2020 Jul 01; 9(7):. PubMed ID: 32630312
    [Abstract] [Full Text] [Related]

  • 6. A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose.
    Joly JH, Delfarah A, Phung PS, Parrish S, Graham NA.
    J Biol Chem; 2020 Jan 31; 295(5):1350-1365. PubMed ID: 31914417
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The cystine/glutamate antiporter xCT is a key regulator of EphA2 S897 phosphorylation under glucose-limited conditions.
    Teramoto K, Katoh H.
    Cell Signal; 2019 Oct 31; 62():109329. PubMed ID: 31152846
    [Abstract] [Full Text] [Related]

  • 9. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
    Ungard RG, Linher-Melville K, Nashed MG, Sharma M, Wen J, Singh G.
    Mol Pain; 2019 Oct 31; 15():1744806918822185. PubMed ID: 30799686
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cystine and glutamate transport in renal epithelial cells transfected with human system x(-) (c).
    Bridges CC, Zalups RK.
    Kidney Int; 2005 Aug 31; 68(2):653-64. PubMed ID: 16014042
    [Abstract] [Full Text] [Related]

  • 13. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
    Polewski MD, Reveron-Thornton RF, Cherryholmes GA, Marinov GK, Aboody KS.
    Stem Cells Dev; 2017 Sep 01; 26(17):1236-1246. PubMed ID: 28610554
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P, Zhuang L, Gan B.
    Protein Cell; 2021 Aug 01; 12(8):599-620. PubMed ID: 33000412
    [Abstract] [Full Text] [Related]

  • 17. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway.
    Chen RS, Song YM, Zhou ZY, Tong T, Li Y, Fu M, Guo XL, Dong LJ, He X, Qiao HX, Zhan QM, Li W.
    Oncogene; 2009 Jan 29; 28(4):599-609. PubMed ID: 19015640
    [Abstract] [Full Text] [Related]

  • 18. Rotavirus-induced lncRNA SLC7A11-AS1 promotes ferroptosis by targeting cystine/glutamate antiporter xCT (SLC7A11) to facilitate virus infection.
    Banerjee S, Sarkar R, Mukherjee A, Mitra S, Gope A, Chawla-Sarkar M.
    Virus Res; 2024 Jan 02; 339():199261. PubMed ID: 37923170
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.